Increased levels of glial-derived and/or TF+MPs are also noted in glioblastoma multiforme (GBM) patients both before and even more so after the neoplasm is treated, suggesting a contribution of TF+/GFAP-MPs to the risk of VTE [87]. This evidence concerns the gene GFAP and glioblastoma.